alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Commissioners 

R. Tyler Bland, Ifl 

Chair 

Vishnu K. Lakdawalu, PhD 

Vice-Chair 

Parris D. Carson 

B. Anne Davis 

Douglas E. Miller 

Frederick N. Elofson, CPA, PFS 

Gcmld S. Johllson 

Michael E. Glelln 

Serving the Cities or 

Chesapeake 

Hampton 

Newport News 

Norfolk 

Poquoson 

Portsmouth 

Suffolk 

Virginia Beaeh 

Willi"amsburg 

Serving the Counties of 

Gloucester 

Isle of Wight 

James City 

King & Queen 

King William 

Mathews 

Middlesex 

York 

HRSD 

P.O. BOX 5911, VIRGINIA BEACH, VIRGINIA 23471-0911' (757) 460-7004· FAX: (757) 318-6452 

February 2, 2009 

EPA Docket Center (EP NnC) 

United States Environmental Protection Agency (EPA) 

U.S. EPA (2822T) 

1200 Pennsylvania Avenue NW 

Washington, D.C. 20460 

www.hrsd.com 

RE: Comments on U.S. EPA's Advanced Notice of Proposed Rulemaking 

(ANPRM) 74 Fed. Reg. 41, January 2, 2009, "Identification of NonHazardous Materials That Are Solid Waste" 

Attention Docket il No. EPA-HQ-OAR-2008-0329 

Dear Sir or Madam: 

The Hampton Roads Sanitation District (HRSD) provides wastewater collection 

and treatment services for 1.6 million people in 17 counties and cities throughout 

Southeast Virginia. HRSD has over 500 miles of pipe, 104 pump stations, and 13 

plants that cover a 3100 square mile service area capable of treating 231 million 

gallons per day of wastewater to protect the Chesapeake Bay. HRSD utilizes a 

variety of biosolids handling options including compo sting, land application, and 

incineration that are beneficial and protective of public health. 

HRSD appreciates the opportunity to provide the EPA the following comments on 

the subject ANPRM. HRSD agrees with and supports the comments of the 

National Association of Clean Water Agencies (NACW A). NACW A and HRSD 

continue to hold the position that "solid waste" does not include sewage sludge 

(biosolids) at Publicly Owned Treatment Works (POTWs). The Congressional 

Domestic Sewage Exclusion (42 U.S.c. 6903(27)) and the Resource Conservation 

and Recovery Act's solid waste definition that applies to sewage sludge supports 

the conclusion that sewage sludge incinerators (SSIs) should continue to be 

regulated under Section 112 and not under Section 129 of the Clean Air Act 

(CAA). 

HRSD supports regulation of SSIs under Section 112 for hazardous air pollutants 

as needed to protect human health and the environment. EPA had recently 

confirmed and reconfirmed in 2005 and 2007 that SSIs should be regulated under 

Section 112 instead of Section 129. Including wastewater sewage sludge as a 

solid waste will contradict these decisions. We request that EPA clarify in its 

PROVIDING WASTEWATER SERVICES TO PROTECT AND ENHANCE OUR ENVIRONMENT
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel Cooperative Multicenter Neonatal Research Network.                    

*Date:*                         December 6-7, 2000.                    

*Time:*                         8:30 am to 5:00 pm.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ramada Inn, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Gopal M. Bhatnagar, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, National Institutes of Health, PHS, DHHS, 9000 Rockville Pike, 6100 Bldg., Room 5E01, Bethesda, MD 20892, (301) 496-1485.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, Contraception and Infertility Loan Repayment Program; 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research, National Institutes of Health, HHS)

Dated: October 25, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-28108  Filed 11-1-00; 8:45 am]

BILLING CODE 4140-01-M
EPA SANITIZED Page 1 of 3
STRUCTURE ACTIVITY TEAM REPORT 04 February 2005 

CASE NUMBER: P05-0186

RELATED CASES: 

CONCLUSIONS/DISCUSSIONS 

TYPE OF CONCERN: HEALTH ECOTOX

LEVEL OF CONCERN: 2 3 

KEYWORDS: LUNG, IRR-MM,E,S, AQUATOX-A,C 

SUMMARY OF ASSESSMENT 

FATE: with 70% <1000 and 50% <500 with N FGEW expect to be very low and expected 

to be less than 400 and percent expected to be equal to greater than 3.5% 

liquid with mp < 20 C (P) 

log Kow for and the = 4.0 (EPI) 

S = 29 mg/L at 25 C, pH 7 (P) but some components are capable of being dispersible in water at 

pH 7 as the CL salt based on analogs 

H = 1.2E-7 (P) 

bp = 290 C (P) 

vp = 3.5E-3 mm Hg or torr at 25 C (P) 

log Koc = 3.1 (P) 

log fish BCF < 2.4 (P) 

POTW removal = 50 to 90% via sorption 

time for complete ultimate aerobic biodegradation > months 

sorption to soils and sediments = low to very strong 

PBT Potential: P3B1T1 

*CEB FATE: migration to ground water = negligible to rapid 

HEALTH: Absorption of the LMW weight fractions (50% <500 and 70% <1000) is moderate 

all routes based on physical/chemical properties; concern for lung effects if respirable droplets 

are inhaled based on cationic binding to lung tissues; concern for irritation to all membranes 

based on the expectation of strong irritation to the eyes, mucous membranes, and skin based on 

the , NOTE: the MSDS calls the material corrosive;moderate concern for irritation 

*CEB HEALTH: Inhalation and dermal 

ECOTOX: Predicted (P) and measured (M) toxicity values in mg/L (ppm) are: 

fish 96-h LC50 <= 0.280 P 

daphnid 48-h LC50 <= 0.100 P 

green algal 96-h EC50 <= 0.040 P 

fish chronic value <= 0.020 P 

EPA SANITIZED Page 2 of 3
daphnid ChV <= 0.007 P 

algal ChV <= 0.020 P 

Predictions are based on SARs for at pH 7 as CL salt with dilution water hardness 

< 150 mg/L as CaCO3 and TOC < 2.0 mg/L; SAR chemical class = and); 

(lowest) to >1000 with 70% <1000 and 48% <500; pH7; effective concentrations based on 

100% active ingredients and mean measured concentrations; hardness <150.0 mg/L as CaCO3; 

and TOC <2.0 mg/L; high concern for toxicity 

significant mitigation of toxicity may occur in the presence of 10 mg TOC/L, i.e.,as high as 

about 60X, but cannot be predicted for this reaction product; moderate concern for 

environmental risk assessment factor = 10.0 

concern concentration = 0.010 mg/L (ppm) with at least 10X mitigation of toxicity expected in 

the presence of 10 mg TOC/L 

*CEB ECOTOX: All releases to water with CC = 10 ppb 

SAT co-chair: Vince Nabholz, 564.8909

EPA SANITIZED Page 3 of 3
****EXHIBIT 8.1****

 

 

**JINPAN INTERNATIONAL LIMITED AND PRINCIPAL SUBSIDIARIES**

 

**AS OF DECEMBER 31, 2008**

 

 

| **Name**                                 | **State of Incorporation**       |
|------------------------------------------|----------------------------------|
| Jinpan International (USA) Limited       | State of New York                |
| Jinpan Electric (China) Company Limited  | People’s Republic of China |
| Hainan Jinpan Electric Company Limited   | People’s Republic of China |
| Wuhan Jinpan Electric Company Limited    | People’s Republic of China |
| Shanghai Jinpan Electric Company Limited | People’s Republic of China |
| Hainan Jinpan R&D Company Limited    | People’s Republic of China |
|                                     |                             |
September 18, 2015

Mr. Jeremiah Terhark

Webspec Design, LLC

5907 Meredith Drive

Urbandale, IA 50322

Dear Mr. Terhark:

This letter is to inform you that we are unable to process your petition for an exemption from 

§§ 45.23(b), 61.3, 91.7(a), 91.9(b)(2), 91.103, 91.109, 91.119, 91.121, 91.151(a), 91.203(a) 

and (b), 91.205(b), 91.215, 91.405(a), 91.407(a)(1), 91.409(a)(2), 91.417(a) and (b), and part 

21 of Title 14, Code of Federal Regulations (14 CFR). It explains why we cannot process 

your request and what you should do in the next 30 days.

Why We Cannot Process Your Request

We received your June 6, 2015, exemption request filed in Docket No. FAA−2015−2703, but 

we are unable to process your request any further. Your petition does not comply with the 

requirements of § 11.81 (copy enclosed). For us to consider the request any further, you must 

send us all of the following:

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole.

 Any additional information, views, or arguments available to support your request.

For more detailed information relating to submitting petitions for exemption, please visit 

http://aes.faa.gov/petition/index.html. This website helps the petitioner to meet Federal 

Aviation Administration (FAA) requirement outlines in § 11.81 and helps answer any 

questions you may have.

What You Should Do

If you want us to process your request any further, you must submit the requested information 

within 30 days. Please note that § 11.63(d) requires you to send your petition for exemption 

at least 120 days before the proposed effective date of the exemption. 
2

If We Do Not Hear From You

If we do not receive the information, we will close the docket without notifying you further. 

If you have any questions you may call the 333 Information Line (202) 267-2999.

Sincerely,

/s/

Brittany Newton

Program Analyst, Airmen and

Airspace Rules Division

Enclosures
3
4
I 

113TH CONGRESS 

1ST SESSION H. R. 3119 

To prohibit enrollment under Health Care Exchange plans until privacy 

protections are certified as being in place, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 18, 2013 

Mr. PAULSEN (for himself, Mr. LANCE, Mr. REED, and Mr. KLINE) introduced the following bill; which was referred to the Committee on Energy 

and Commerce 

A BILL 

To prohibit enrollment under Health Care Exchange plans 

until privacy protections are certified as being in place, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Health Information 

5 Privacy Protection Act of 2013’’. 


pwalker on DSK7TPTVN1PROD with BILLS
2 

•HR 3119 IH

1 SEC. 2. PROHIBITING ENROLLMENT UNDER AN EXCHANGE 

2 PLAN UNLESS PRIVACY PROTECTIONS IN 

3 PLACE. 

4 Notwithstanding any other provision of law, no indi5 vidual may be enrolled in a qualified health plan offered 

6 in a State through an Exchange under part 2 of subtitle 

7 D of title I of the Patient Protection and Affordable Care 

8 Act (42 U.S.C. 18031 et seq.) until the date the State 

9 certifies to the Secretary of Health and Human Services 

10 and the Secretary certifies to Congress that there are 

11 standards and a process in place in the State to protect 

12 the personal information (including Social Security num13 bers and financial information) of individuals being en14 rolled through the Exchange. 

Æ 


pwalker on DSK7TPTVN1PROD with BILLS
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 19-10011

STATE OF TEXAS; STATE OF ALABAMA; STATE OF ARIZONA; STATE 

OF FLORIDA; STATE OF GEORGIA; STATE OF INDIANA; STATE OF 

KANSAS; STATE OF LOUISIANA; STATE OF MISSISSIPPI, by and 

through Governor Tate Reeves;1 STATE OF MISSOURI; STATE OF 

NEBRASKA; STATE OF NORTH DAKOTA; STATE OF SOUTH 

CAROLINA; STATE OF SOUTH DAKOTA; STATE OF TENNESSEE; 

STATE OF UTAH; STATE OF WEST VIRGINIA; STATE OF ARKANSAS; 

NEILL HURLEY; JOHN NANTZ, 

 Plaintiffs - Appellees

v.

UNITED STATES OF AMERICA; UNITED STATES DEPARTMENT OF 

HEALTH; HUMAN SERVICES; ALEX AZAR, II, SECRETARY, U.S. 

DEPARTMENT OF HEALTH AND HUMAN SERVICES; UNITED STATES 

DEPARTMENT OF INTERNAL REVENUE; CHARLES P. RETTIG, in his 

Official Capacity as Commissioner of Internal Revenue, 

 Defendants - Appellants

STATE OF CALIFORNIA; STATE OF CONNECTICUT; DISTRICT OF 

COLUMBIA; STATE OF DELAWARE; STATE OF HAWAII; STATE OF 

ILLINOIS; STATE OF KENTUCKY, ex rel. Andy Beshear, Governor; STATE 

OF MASSACHUSETTS; STATE OF NEW JERSEY; STATE OF NEW YORK; 

STATE OF NORTH CAROLINA; STATE OF OREGON; STATE OF RHODE 

ISLAND; STATE OF VERMONT; STATE OF VIRGINIA; STATE OF 

WASHINGTON; STATE OF MINNESOTA, 

 Intervenor Defendants - Appellants

1 Governor Tate Reeves is substituted pursuant to Federal Rule of Appellate 

Procedure 43(c)(2).

United States Court of Appeals

Fifth Circuit

FILED

January 29, 2020

Lyle W. Cayce

Clerk
No. 19-10011

2

Appeals from the United States District Court

for the Northern District of Texas

Before KING, ELROD, and ENGELHARDT, Circuit Judges.

PER CURIAM:

The court having been polled at the request of one of the members of the 

court and a majority of the judges who are in regular active service and not 

disqualified not having voted in favor (FED. R. APP. P. 35 and 5TH CIR. R. 35), 

rehearing en banc is DENIED.2

In the poll, 6 judges voted in favor of rehearing en banc, and 8 voted 

against. Judges Smith, Stewart, Dennis, Graves, Higginson, and Costa voted 

in favor. Chief Judge Owen and Judges Jones, Elrod, Southwick, Haynes, 

Willett, Duncan, and Engelhardt voted against.

ENTERED FOR THE COURT:

/s/ Jennifer Walker Elrod

_____________________________

Jennifer Walker Elrod

United States Circuit Judge

2 Judges Ho and Oldham are recused and did not participate in the en banc poll.
EXHIBIT 32.2
                                  ------------

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Nexicon, Inc. (the "Company") on
Amendment No. 4 to Form 10-KSB for the fiscal year ended December 31, 2004 as
filed with the United States Securities and Exchange Commission on the date
hereof (the "Report"), the undersigned, in the capacities and on the dates
indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:

1.    The Report fully complies with the requirements of Section 13(a) or 15(d)
      of the Securities Exchange Act of 1934, as amended; and

2.    The information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operation of the Company.

Date: February 10, 2006                    NEXICON, INC.

                                           By:      /s/ Daniel Urrea
                                                    ----------------
                                                    Daniel Urrea
                                                    Chief Financial Officer and
                                                    Principal Accounting Officer

A signed original of this written statement required by Section 906, or other
document authentications, acknowledging, or otherwise adopting the signature
that appears in typed form within the electronic version of this written
statement required by Section 906, has been provided to Nexicon, Inc. and will
be retained by Nexicon, Inc. and furnished to the United States Securities and
Exchange Commission or its Staff upon request.
IN THE SUPREME COURT OF PENNSYLVANIA 

EASTERN DISTRICT 

COMMONWEALTH OF PENNSYLVANIA, 

 Respondent 

 v. 

HALEEM POOLE, 

 Petitioner 

:

:

:

:

:

:

:

:

:

:

:

No. 279 EAL 2015 

Petition for Allowance of Appeal from 

the Order of the Superior Court 

ORDER 

PER CURIAM 

AND NOW, this 7th day of October, 2015, the Petition for Allowance of Appeal is 

DENIED.
IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Gregory Thomas, :

Appellant :

:

v. : No. 905 C.D. 2018

:

C/O Jason Pyle, :

C/O James Mainello, :

Captain B. Harris, :

HEX. S. Ellenberger, :

Unit Manager M. Goss, :

D. Supt. J. Thomas, :

Acting Deputy Supt. S. Walters, :

K. Kauffman Supt., :

C. HEX Joseph H. Dupont, :

Sued in Their Individual and :

Official Capacity :

O R D E R

NOW, January 8, 2019, having considered appellant’s application for 

reconsideration, the application is denied.

 

 MARY HANNAH LEAVITT,

 President Judge
[Federal Register Volume 65, Number 208 (Thursday, October 26, 2000)]
[Notices]
[Page 64222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-27546]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N-1268]


Agency Information Collection Activities; Announcement of OMB 
Approval; Food Additives and Food Additive Petitions

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Food Additives and Food Additive 
Petitions'' has been approved by the Office of Management and Budget 
(OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Peggy Schlosburg, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 3, 2000 
(65 FR 47736), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0016. 
The approval expires on October 31, 2003. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.fda.gov/ohrms/dockets.

    Dated: October 20, 2000.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 00-27546 Filed 10-25-00; 8:45 am]
BILLING CODE 4160-01-F
Exhibit 99


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Merrill Lynch Preferred
Capital Trust IV (the "Trust") and Merrill Lynch  Preferred  Funding IV, L.P.
(the "Partnership")  for the period ended December 27, 2002 as filed with the
Securities and Exchange  Commission on the date hereof (the "Report"),  I,
John C. Stomber, Regular  Trustee of the Trust and Senior Vice President and
Treasurer of Merrill Lynch & Co., Inc., the General Partner of the Partnership,
certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d)
    of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
    respects, the financial condition and results of operations of the Trust
    and the Partnership.




                              MERRILL LYNCH PREFERRED CAPITAL TRUST IV


                              By:  /s/ JOHN C. STOMBER
                              --------------------------------------------
                              Name:  John C. Stomber *
                              Title: Regular Trustee




                               MERRILL LYNCH PREFERRED FUNDING IV, L.P.


                               By: MERRILL LYNCH & CO., INC., as General Partner



                               By:  /s/ JOHN C. STOMBER
                               --------------------------------------------
                               Name:  John C. Stomber *
                               Title: Senior Vice President and Treasurer


Dated: March 26, 2003
_______________________

*  John C. Stomber functions as the equivalent of the Chief Executive Officer
   and Chief Financial Officer of each of the Trust and the Partnership for
   purposes of Section 906 of the Sarbanes-Oxley Act of 2002.
Page 1 of 1 Meeting Summary

EPA/ Iofina Chemical Inc. April 12, 2011

, 10:30 AM to 11:30 AM

Room S

- 9 621 , 2777 S. Crystal Drive, Arlington, VA 22202

Participants

Iofina Chemical Inc.: Tom Becker and Kurt Jones

EPA: Patricia Moe, Lance Wormell , Stacey Grigsby, Jaclyn Carl, Rebecca von dem Hagen

Summary On Tuesday, April 12, 2011

, Pesticide Reevaluation Division ( PRD ) and Antimicrobials Division ( AD ) hosted a meeting with trichloromelamine ( TCM ) registrant Iofina Chemical Inc. The registrant requested the meeting with two divisions in EPA’s Office of Pesticide Programs to discuss Data Call

- Ins issued as a result of the 2005 RED. The registrant requested to meet with PRD’s Risk Management and Implementation Branch V (RMIB V) to discuss the RED Product Specific Data Call

- In (PDCI) issued in October 2008. The registrant also requested the meeting to discuss the RED Generic Data Call

- In (GDCI) wi th AD , specifically regarding the status of Iofina’s waiver requests.

Next Steps EPA will continue to work with Iofina and respond to waiver requests in the near future.